End Point Selection in ADPKD Clinical Trials
Ragada El-Damanawi, Julia Jefferis, David W. Johnson, Carmel M. Hawley et autres
0 citationsKidney International Reports
Ragada El-Damanawi
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
25Publications signalées
265Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Genetic and Kidney Cyst DiseasesRenal Diseases and GlomerulopathiesGenetic Syndromes and ImprintingHedgehog Signaling Pathway StudiesRenal and related cancers
Publications récentes
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
Ragada El-Damanawi, David W. Johnson, Carmel M. Hawley, Andrea K. Viecelli et autres
3 citationsTrials
Implementation of Metformin theraPy to Ease DEcline of kidney function in Polycystic Kidney Disease (IMPEDE-PKD): randomised placebo-controlled trial
Megan Jones, Ragada El-Damanawi
0 citationshttp://isrctn.com/
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial
Toby J L Humphrey, Wendi Qian, Michael Chen-Xu, Francis Dowling et autres
0 citationsBMC Infectious Diseases
End Point Selection in ADPKD Clinical Trials
Kitty St Pierre, Ragada El-Damanawi, Julia Jefferis, David W Johnson et autres
0 citationsResearchOnline - JCU (James Cook University)
Metformin for preventing the progression of chronic kidney disease
Ragada El-Damanawi, Isabelle Kitty Stanley, Christine E. Staatz, Elaine M. Pascoe et autres
14 citationsCochrane Database of Systematic Reviews
Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
Andrew Mallett, Ronald D. Perrone, Gopala K. Rangan, Carmel M. Hawley et autres
0 citationsKidney International Reports
Developing a patient-centred tool for pain measurement and evaluation in autosomal dominant polycystic kidney disease
Ragada El-Damanawi, Michael Lee, Tess Harris, Laura Cowley et autres
15 citationsClinical Kidney Journal
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) Consensus Workshop
Yeoungjee Cho, Allison Tong, Jonathan C. Craig, Reem A. Mustafa et autres
54 citationsAmerican Journal of Kidney Diseases
SO090EVALUATING PAIN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Ragada El-Damanawi, Tess Harris, Laura Cowley, Fiona E. Karet et autres
1 citationNephrology Dialysis Transplantation
Assessing Disease Modifying Therapies in Autosomal Dominant Polycystic Kidney Disease
0 citationsApollo (University of Cambridge)
SAT-447 PER TREATMENT POST-HOC ANALYSIS OF CLINICAL TRIAL OUTCOMES WITH TOLVAPTAN (TLV) IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
Andrew Mallett, Ronald D. Perrone, Gopala K. Rangan, Carmel M. Hawley et autres
0 citationsKidney International Reports
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.